NHS Branded Medicines Tranche Framework for London and South of England
Buyers
Value
£380,950,720
Suppliers
- Sun Pharma UK Ltd
- Biogen
- Merck Sharpe & Dohme (UK) Limited
- Celltrion Healthcare United Kingdom Limited
- AstraZeneca
- Janssen-Cilag Ltd
- Organon Pharmaceuticals UK Ltd
- Thornton and Ross Ltd
- GLAXOSMITHKLINE UK LIMITED
- Takeda UK Ltd
- Pfizer Ltd
- Novartis Pharmaceuticals UK Ltd
- Zentiva Pharma UK Ltd
- Roche Products Ltd
- Eli Lilly & Company Ltd
- Aventis Pharma ltd t/a Sanofi
- ACCORD-UK LTD
- Orifarm UK
- Galapagos Biotech Ltd
- Manx Healthcare Ltd
- Chugai Pharma UK Ltd
- Napp Pharmaceuticals Ltd
- Dr.Reddy's Laboratories (UK) Limited
- LEO Pharma
- Gedeon Richter UK Ltd
- BIOSIMILAR COLLABORATIONS IRELAND LIMITED
- Sobi (Swedish Orphan Biovitrum Ltd)
- Teva UK Limited
- UCB Pharma Ltd (primary)
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
7 months ago
Published
3 months ago
Description
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024 Offer reference number: CM/PHR/22/5689 CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete